Background. Adrenocortical carcinoma is a rare and aggressive disease with a poor prognosis. Adjuvant mitotane administration has been suggested as a strategy that might improve the outcome of patients with localized disease. Methods. The authors analyzed the clinical out- come of patients with loc
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
โ Scribed by Anna A. Kasperlik-Zauska; Barbara Migdalska; Anna Makowska; Rena Vassilopoulou-Sellin; Vincent F. Guinee; Sarah H. Taylor; Kenneth R. Hess
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 322 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## METHODS. In this retrospective study, all 348 patients admitted to the Edmonton Palliative Care Program, Grey Nuns Community General Palliative Care Unit over a period of 26 months were reviewed. The Mini-Health Centre, Cross Cancer Institute, University Mental State Examination (MMSE) was used
## BACKGROUND. Stage and histologic type have a significant impact on the long term clinical course of breast carcinoma. Clinical course is governed by two components: likelihood of cure and median tumor-related survival time among uncured patients. Estimates of these components can be derived only